The action of stimulant medication in attention deficit disorder with hyperactivity: dopaminergic, noradrenergic, or both?

Suppr

超能文献

作者信息

Levy F, Hobbes G

出版信息

J Am Acad Child Adolesc Psychiatry. 1988 Nov;27(6):802-5. doi: 10.1097/00004583-198811000-00025.

DOI:10.1097/00004583-198811000-00025

PMID:2848797

Abstract

摘要

相似文献

The action of stimulant medication in attention deficit disorder with hyperactivity: dopaminergic, noradrenergic, or both?

J Am Acad Child Adolesc Psychiatry. 1988 Nov;27(6):802-5. doi: 10.1097/00004583-198811000-00025.

The mechanism of action of drugs used to treat attention-deficit hyperactivity disorder: focus on catecholamine receptor pharmacology.用于治疗注意力缺陷多动障碍的药物作用机制：聚焦于儿茶酚胺受体药理学

Adv Pediatr. 1992;39:337-82.

Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.使用兴奋剂药物治疗的注意力缺陷多动障碍儿童出现抽动症状。

Compr Psychiatry. 2001 May-Jun;42(3):228-33. doi: 10.1053/comp.2001.23145.

Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.哌甲酯对注意缺陷/多动障碍儿茶酚胺能系统的影响。

J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S46-53. doi: 10.1097/JCP.0b013e318173312f.

Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.肾上腺素能α2A受体基因与哌甲酯改善注意缺陷多动障碍儿童及青少年注意力不集中症状的相关性

Arch Gen Psychiatry. 2007 Feb;64(2):218-24. doi: 10.1001/archpsyc.64.2.218.

A two-part model of stimulant action on attention-deficit hyperactivity disorder in children.儿童注意力缺陷多动障碍兴奋剂作用的两部分模型。

J Neuropsychiatry Clin Neurosci. 1991 Spring;3(2):201-9. doi: 10.1176/jnp.3.2.201.

Antidepressant mechanisms.

J Am Acad Child Adolesc Psychiatry. 1994 Jan;33(1):142. doi: 10.1097/00004583-199401000-00019.

Methylphenidate HCl: therapy for attention deficit hyperactivity disorder.

Expert Rev Neurother. 2005 May;5(3):325-31. doi: 10.1586/14737175.5.3.325.

[Alterations in the pattern of dopaminergic markers in attention-deficit/hyperactivity disorder].[注意缺陷多动障碍中多巴胺能标志物模式的改变]

Rev Neurol. 2006 Feb 13;42 Suppl 2:S19-23.

Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.与缓释混合安非他明盐相比，使用盐酸哌甲酯控释片进行兴奋剂治疗对改善患有注意力缺陷多动障碍的青少年驾驶员驾驶性能的相对益处。

Pediatrics. 2006 Sep;118(3):e704-10. doi: 10.1542/peds.2005-2947.

引用本文的文献

Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype: Possible Relevance to Attention-Deficit Hyperactivity Disorder.多巴胺能神经元中CB2大麻素受体的细胞类型特异性缺失诱导多动表型：与注意力缺陷多动障碍的可能关联。

Front Psychiatry. 2022 Feb 8;12:803394. doi: 10.3389/fpsyt.2021.803394. eCollection 2021.

Pharmacological and therapeutic directions in ADHD: Specificity in the PFC.ADHD 的药理学和治疗方向：PFC 的特异性。

Behav Brain Funct. 2008 Feb 28;4:12. doi: 10.1186/1744-9081-4-12.

Pharmacokinetic and pharmacodynamic drug interactions in the treatment of attention-deficit hyperactivity disorder.注意缺陷多动障碍治疗中的药代动力学和药效学药物相互作用。

Clin Pharmacokinet. 2001;40(10):753-72. doi: 10.2165/00003088-200140100-00004.

Does haloperidol block methylphenidate? Motivation or attention?氟哌啶醇会阻断哌甲酯的作用吗？是动机还是注意力方面？

Psychopharmacology (Berl). 1996 Jul;126(1):70-4. doi: 10.1007/BF02246413.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验